Advisor Group Holdings, Inc. Pa Vmed Inc. Transaction History

Advisor Group Holdings, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$0.35 - $0.56 $105 - $168	-300 Reduced 6.35%	4,425 $1,000
Q1 2023 May 12, 2023	BUY	$0.36 - $0.63 $288 - $504	800 Added 20.38%	4,725 $1,000
Q4 2022 Feb 10, 2023	SELL	$0.41 - $18.6 $2,086 - $94,674	-5,090 Reduced 56.46%	3,925 $1,000
Q3 2022 Nov 14, 2022	BUY	$0.57 - $34.65 $1,379 - $83,853	2,420 Added 36.69%	9,015 $8,000
Q1 2022 May 04, 2022	BUY	$1.16 - $2.5 $3,280 - $7,070	2,828 Added 75.07%	6,595 $9,000
Q3 2021 Nov 05, 2021	BUY	$5.1 - $9.39 $7,481 - $13,775	1,467 Added 63.78%	3,767 $32,000
Q2 2021 Aug 02, 2021	SELL	$3.95 - $6.88 $19,750 - $34,400	-5,000 Reduced 68.49%	2,300 $15,000
Q1 2021 May 13, 2021	BUY	$2.01 - $5.55 $9,647 - $26,640	4,800 Added 192.0%	7,300 $33,000
Q4 2020 Feb 10, 2021	SELL	$1.73 - $2.13 $6,920 - $8,520	-4,000 Reduced 61.54%	2,500 $5,000
Q3 2020 Nov 12, 2020	BUY	$1.76 - $2.17 $7,920 - $9,765	4,500 Added 225.0%	6,500 $12,000
Q1 2020 May 18, 2020	BUY	$1.15 - $3.29 $2,300 - $6,580	2,000 New	2,000 $4,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $60.1M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.